|
|
Volumn 12, Issue 2, 2001, Pages 255-257
|
|
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
|
|
Author keywords
Brain tumours; Chemotherapy; Recurrent; Temozolomide
|
|
Indexed keywords
NITROSOUREA;
ONDANSETRON;
PROCARBAZINE;
TEMOZOLOMIDE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
GASTROINTESTINAL TOXICITY;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
LEUKOPENIA;
LIVER TOXICITY;
MALE;
MEDICAL ASSESSMENT;
MULTIVARIATE ANALYSIS;
NEUROSURGERY;
OLIGODENDROGLIOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
DACARBAZINE;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GLIOMA;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
|
|
EID: 0035101008
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008336732273 Document Type: Article |
|
Times cited : (89)
|
|
References (11)
|
